Published in Lancet on October 01, 1994
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Retracted The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem (2007) 2.60
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax (1998) 2.04
A random forest approach to the detection of epistatic interactions in case-control studies. BMC Bioinformatics (2009) 2.03
MicroRNAs and cardiovascular diseases. FEBS J (2011) 1.41
Epistasis between calpain 1 and its inhibitor calpastatin within breeds of cattle. Genetics (2007) 1.34
Epistatic module detection for case-control studies: a Bayesian model with a Gibbs sampling strategy. PLoS Genet (2009) 1.17
Automated detection of informative combined effects in genetic association studies of complex traits. Genome Res (2003) 1.06
Quantitative trait loci associated with blood pressure of metabolic syndrome in the progeny of NZO/HILtJxC3H/HeJ intercrosses. Mamm Genome (2007) 1.02
Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol (2010) 0.98
Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet (1995) 0.95
Molecular genetics of myocardial infarction. Genomic Med (2008) 0.91
Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system. Curr Hypertens Rep (2011) 0.90
Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn (2000) 0.88
Renin-angiotensin system polymorphisms and renal scarring. Pediatr Nephrol (2002) 0.87
Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry (2007) 0.86
Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population. BMC Res Notes (2014) 0.86
RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. BMC Cardiovasc Disord (2008) 0.86
Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J (1995) 0.85
Translational study of microRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond) (2012) 0.85
Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol (2008) 0.84
Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet (2007) 0.83
Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr Nephrol (2002) 0.82
Increased risk for ischaemic events is related to combined RAS polymorphism. Heart (2001) 0.80
Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest (1995) 0.80
Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status. Dis Markers (2015) 0.80
Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases. Eur J Pharmacol (2015) 0.79
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms. Thromb J (2003) 0.78
Cardiovascular disease and genetics of the renin-angiotensin system. Heart (1996) 0.77
The angiotensin converting enzyme gene in cardiovascular disease. Br Heart J (1995) 0.77
The renin-angiotensin system and the heart: beyond 2000. Heart (1996) 0.76
Association between angiotensin II type 1 receptor polymorphism and sudden cardiac death in myocardial infarction. Dis Markers (2013) 0.76
Genetics of coronary disease: beginning the long journey. Lancet (1994) 0.76
Genes of renin angiotensin system and coronary heart disease. Indian J Clin Biochem (2000) 0.75
Angiotensin II receptor gene polymorphisms and risk of myocardial infarction. Lancet (1994) 0.75
Renin-angiotensin system gene polymorphisms: association with susceptibility to Henoch-Schonlein purpura and renal involvement. Clin Rheumatol (2006) 0.75
Genetics of coronary artery disease and myocardial infarction. World J Cardiol (2016) 0.75
Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction. Indian Heart J (2015) 0.75
Angiotensin converting enzyme genotypes and disease. BMJ (1995) 0.75
New concepts regarding events that lead to myocardial infarction. Cardiovasc Drugs Ther (1995) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci (2001) 10.38
A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage (1995) 8.46
Intellectual ability and cortical development in children and adolescents. Nature (2006) 8.41
Incorporating prior knowledge into image registration. Neuroimage (1997) 8.24
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (1992) 5.56
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A (2007) 5.56
Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer (1989) 4.34
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother (2008) 4.21
Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology (1992) 3.87
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Alternative strategies for stroke care: a prospective randomised controlled trial. Lancet (2000) 3.27
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation (2001) 3.21
Patients with fatigue in general practice: a prospective study. BMJ (1993) 3.14
Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation (2001) 3.12
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology (2008) 3.10
Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02
Retrospective evaluation of intersubject brain registration. IEEE Trans Med Imaging (2003) 3.02
Admission to child health surveillance lists: the views of FHSA general managers and general practitioners. BMJ (1991) 2.82
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc (2001) 2.64
Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage (1999) 2.62
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56
Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension (1996) 2.44
The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer (1981) 2.43
Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut (2001) 2.36
Consultation use of a computer by general practitioners. J R Coll Gen Pract (1984) 2.36
Specific involvement of human parietal systems and the amygdala in the perception of biological motion. J Neurosci (1996) 2.33
Underperforming doctors in general practice: a survey of referrals to UK Deaneries. Br J Gen Pract (2001) 2.33
Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med (2000) 2.28
Functional imaging of an illusion of pain. Nature (1996) 2.26
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25
Stopping drug treatment of hypertension: experience in 18 British general practices. Br J Gen Pract (1999) 2.22
Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation (1994) 2.18
Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J Am Coll Cardiol (1999) 2.13
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08
Obesity and the lung: 1. Epidemiology. Thorax (2008) 2.08
Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology (1993) 2.07
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
Simulated surgery in the summative assessment of general practice training: results of a trial in the Trent and Yorkshire regions. Br J Gen Pract (1998) 2.05
MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology (1993) 2.04
The successful development of decentralised health service management: an evaluation of area health services in New South Wales. Aust Health Rev (1992) 1.97
Impact of NHS direct on demand for immediate care. Target communities show poor awareness of NHS direct. BMJ (2000) 1.96
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989) 1.96
Trends in the relative frequency of histologically diagnosed epithelial dysplasia and intra-oral carcinoma in Northern Ireland, 1975-1989. Br Dent J (1992) 1.95
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia (2009) 1.93
Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr (2010) 1.92
Effect of computer use in the consultation on the delivery of care. Br Med J (Clin Res Ed) (1985) 1.90
Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet (1994) 1.85
Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (1999) 1.78
X-ray refraction effects: application to the imaging of biological tissues. Br J Radiol (2003) 1.73
An interactive computerized protocol for the management of hypertension: effects on the general practitioner's clinical behaviour. J R Coll Gen Pract (1986) 1.72
Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme. Clin Radiol (2010) 1.72
Medicaid managed care in thirteen states. Health Aff (Millwood) (1998) 1.71
Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health (2001) 1.69
Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology (1999) 1.67
Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64
Care-seeking among individuals with chronic low back pain. Spine (Phila Pa 1976) (1995) 1.63
Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl (1985) 1.63
Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas (2009) 1.61
Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry (1995) 1.59
Predicting survival after treatment for fracture of the proximal femur and the effect of delays to surgery. J Clin Epidemiol (2003) 1.57
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57